← Open Payments lookup

MAYA BEPLAT: Open Payments

NPI 1043722655 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,070 in 61 payments from 25 companies in 2025. Trend: 2023 $1,551 · 2024 $1,482 · 2025 $2,070

Food & beverage: $1,878Education: $192
CompanyPaymentsAmount
Janssen Biotech, Inc.8$446
Daiichi Sankyo Inc.10$234
Gilead Sciences, Inc.3$195
ABBVIE INC.3$172
Novartis Pharmaceuticals Corporation7$167
Lilly USA, LLC2$116
JAZZ PHARMACEUTICALS INC.2$101
Merck Sharp & Dohme LLC4$93
TerSera Therapeutics LLC3$60
Stemline Therapeutics Inc.2$56

Products named: RYBREVANT, ERLEADA, Trodelvy, VENCLEXTA, Enhertu, DATROWAY, ZEPZELCA, KISQALI.

Industry payments across DC — which companies pay providers there.